{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:05:36Z","timestamp":1793822736259,"version":"4.6.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,7]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Nasopharyngeal carcinoma has a high incidence in East and Southeast Asia, often with distant metastasis. However, leptomeningeal metastasis (LM) is extremely rare and usually has a poor prognosis. This paper reports the clinical treatment of a patient with meningeal metastasis of nasopharyngeal carcinoma (NPC) in order to improve the clinician\u2019s understanding of the disease. Early diagnosis of the disease can alleviate the pain of patients and prolong their survival time.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We report the case of a 55-year-old female with a history of NPC with LM. Brain magnetic resonance imaging showed temporal lobe enhancement, peripheral edema, and enhancement of the adjacent meninges. Cerebrospinal fluid cytology suggests the presence of malignant tumor cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>The patient was diagnosed with LM from NPC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patients were regularly given targeted therapy with nimotuzumab, immunotherapy with karyolizumab, and lumbar intrathecal methotrexate chemotherapy and supportive treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient had survived for 3 years since the diagnosis of LM and was in good condition and still under active antitumor treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Leptomeningeal metastasis of NPC is a rare disease. Although there is currently no unified treatment plan, the neurological symptoms can still be controlled and the quality of life can be improved through active treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037853","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T14:13:59Z","timestamp":1717769639000},"page":"e37853","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Nasopharyngeal carcinoma with leptomeningeal metastases has been treated with comprehensive treatment for long-term survival: A case report and literature review"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9300-3721","authenticated-orcid":false,"given":"Yi","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanghao","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Bu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/S1470-2045(17)30689-7","article-title":"Leptomeningeal metastases in non-small-cell lung cancer.","volume":"19","author":"Cheng","year":"2018","journal-title":"Lancet Oncol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"116706","DOI":"10.1016\/j.jns.2020.116706","article-title":"Leptomeningeal metastasis from solid tumors.","volume":"411","author":"Thakkar","year":"2020","journal-title":"J Neurol Sci"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma.","volume":"394","author":"Cheny","year":"2019","journal-title":"Lancet"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3858\/emm.2011.43.7.044","article-title":"The role of promoter methylation in Epstein\u2013Barr virus (EBV) microRNA expression in EBV-infected B cell lines.","volume":"43","author":"Don","year":"2011","journal-title":"Exp Mol Med"},{"key":"R5-20250503","first-page":"53","article-title":"Progress in diagnosis and treatment of meningeal carcinomatosis.","volume":"43","author":"Xiaosu","year":"2017","journal-title":"Chin J Nerv Ment Dis"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2147\/CMAR.S182154","article-title":"Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis.","volume":"11","author":"El","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"iv84","DOI":"10.1093\/annonc\/mdx221","article-title":"EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours.","volume":"28","author":"Rhun","year":"2017","journal-title":"Ann Oncol"},{"key":"R8-20250503","first-page":"611","article-title":"Guidelines for radiotherapy of nasopharyngeal carcinoma in China (2022 edition).","volume":"29","year":"2022","journal-title":"Chin J Cancer Prev Treat"},{"key":"R9-20250503","first-page":"67","article-title":"Nimotuzumab combined with radiotherapy and chemotherapy in the treatment of locally advanced nasopharyngeal carcinoma.","volume":"42","author":"Yuemei","year":"2014","journal-title":"China Clin"},{"key":"R10-20250503","first-page":"856","article-title":"A preliminary study on the treatment of high-grade glioma with nimotuzumab combined with radiotherapy and temozolomide at the same time.","volume":"19","author":"Yang","year":"2009","journal-title":"China Oncol"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications.","volume":"285","author":"Folkman","year":"1971","journal-title":"N Engl J Med"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12916-016-0623-5","article-title":"Cancer immunotherapy: the beginning of the end of cancer?","volume":"14","author":"Farkona","year":"2016","journal-title":"BMC Med"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S1470-2045(18)30495-9","article-title":"Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials.","volume":"19","author":"Fang","year":"2018","journal-title":"Lancet Oncol"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ctrv.2016.12.006","article-title":"Leptomeningeal carcinomatosis in non-small cell lung cancer patients: a continuing challenge in the personalized treatment era.","volume":"53","author":"Remon","year":"2017","journal-title":"Cancer Treat Rev"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:26:11Z","timestamp":1746318371000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":14,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037853","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,7]]}}}